Reuters logo
BRIEF-‍TherapeuticsMD announces submission of additional endometrial safety information to new drug application for TX-004HR​
September 14, 2017 / 8:36 PM / 2 months ago

BRIEF-‍TherapeuticsMD announces submission of additional endometrial safety information to new drug application for TX-004HR​

Sept 14 (Reuters) - TherapeuticsMD Inc

* ‍TherapeuticsMD announces submission of additional endometrial safety information to new drug application for TX-004HR​

* TherapeuticsMD Inc - ‍Company currently plans to re-submit NDA for TX-004HR shortly after meeting​

* TherapeuticsMD Inc - ‍Scheduled a formal meeting with FDA for November 3, 2017 regarding TX-004HR​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below